Can People With Type 2 Diabetes Use Omnipod?

For years, many people associated Omnipod primarily with Type 1 diabetes.

If you searched for insulin pumps a few years ago, most of the information focused on people with Type 1 diabetes using insulin pump therapy and continuous glucose monitoring (CGM) systems.

But that is beginning to change.

Today, Omnipod 5 is not only used by people with Type 1 diabetes. In the United States, Omnipod 5 is also FDA-cleared for adults with Type 2 diabetes who require insulin therapy, making it the first automated insulin delivery (AID) system approved for both Type 1 and Type 2 diabetes management.

As diabetes technology continues to evolve, many experts believe automated insulin delivery systems will play an increasingly important role in Type 2 diabetes care.

Is Omnipod Only for Type 1 Diabetes?

No.

While Omnipod has historically been most commonly used by people with Type 1 diabetes, Omnipod 5 is now FDA-cleared in the United States for:

• People with Type 1 diabetes aged 2 years and older
• Adults with Type 2 diabetes aged 18 years and older

This marks a significant shift in diabetes care because it expands access to automated insulin delivery technology for a much larger group of people living with diabetes.

If you're new to insulin pump therapy or diabetes technology, you may also want to read our guide explaining what an Omnipod is, how it works, and the differences between Omnipod 5, DASH, and GO.

What Changed?

In August 2024, the U.S. Food and Drug Administration (FDA) expanded the indication for Omnipod 5 to include adults with Type 2 diabetes. At the time, Insulet described Omnipod 5 as the first and only automated insulin delivery system cleared for both Type 1 and Type 2 diabetes management.

For many years, insulin pumps were primarily viewed as tools for Type 1 diabetes. However, as technology improved and research expanded, healthcare providers began exploring how automated insulin delivery could help people with insulin-treated Type 2 diabetes as well.

The results have been promising.

Why Would Someone With Type 2 Diabetes Use Omnipod?

Not every person with Type 2 diabetes uses insulin.

However, some people with Type 2 diabetes eventually require insulin therapy to help manage blood glucose levels.

Traditionally, this often involved:

• Multiple daily injections (MDI)
• Frequent blood glucose checks
• Complex insulin dosing decisions

Automated insulin delivery systems such as Omnipod 5 are designed to reduce some of this burden by adjusting insulin delivery based on glucose data from a compatible CGM system.

Potential benefits may include:

• Fewer daily insulin decisions
• Improved time in range
• Reduced diabetes management burden
• Better overnight glucose control
• Increased flexibility in daily life

Individual experiences vary, and treatment decisions should always be made with a healthcare professional.

What Does the Research Say?

One of the most important studies in this area is the SECURE-T2D pivotal trial, which evaluated Omnipod 5 in adults with Type 2 diabetes.

The study included more than 300 adults with Type 2 diabetes using insulin therapy. Researchers found improvements in several important outcomes after participants began using Omnipod 5.

Reported findings included:

• HbA1c improved from approximately 8.2% to 7.4%
• Time in range increased substantially
• Participants spent less time in hyperglycemia
• Quality-of-life measures improved
• Benefits were observed across a diverse group of adults with Type 2 diabetes

Researchers concluded that automated insulin delivery may be a beneficial and safe option for many adults with insulin-treated Type 2 diabetes.

Omnipod, Dexcom, and Type 2 Diabetes

Many people know Omnipod 5 because of its integration with continuous glucose monitoring technology.

By combining insulin delivery with real-time glucose information, automated insulin delivery systems can help make diabetes management more proactive and personalized.

As adoption grows, it is likely that more adults with Type 2 diabetes will become familiar with systems that combine:

• Insulin pumps
• Continuous glucose monitoring
• Automated insulin delivery algorithms

This is one reason why searches for terms like:

• Omnipod Type 2 diabetes
• Omnipod 5 Type 2 diabetes
• Dexcom and Type 2 diabetes
• Automated insulin delivery for Type 2 diabetes are expected to increase in the coming years.

If you're interested in how Omnipod works together with continuous glucose monitoring technology, read our complete guide to Omnipod and Dexcom compatibility.

Is This the Future of Type 2 Diabetes Care?

No single technology is right for everyone.

However, the broader trend is clear.

Healthcare providers are increasingly exploring technologies that can simplify insulin therapy and improve outcomes for people living with diabetes. Future systems may offer even more advanced automation, which is why many people are already following developments around Omnipod 6 and next-generation automated insulin delivery systems.

Recent clinical research, regulatory approvals, and updated diabetes care guidelines all point toward a growing role for automated insulin delivery in insulin-treated Type 2 diabetes.

For many people, the question is no longer:

"Can people with Type 2 diabetes use an insulin pump?"

Instead, the question is becoming:

"Which diabetes technologies are best suited to my needs?"

Frequently Asked Questions

Can people with Type 2 diabetes use Omnipod?

Yes. In the United States, Omnipod 5 is FDA-cleared for adults aged 18 years and older with Type 2 diabetes who require insulin therapy.

Is Omnipod only for Type 1 diabetes?

No. Omnipod 5 is indicated for both Type 1 diabetes and adults with Type 2 diabetes in the United States.

Does Omnipod work with Type 2 diabetes?

Clinical studies have shown improvements in HbA1c and time in range among adults with Type 2 diabetes using Omnipod 5.

Why would someone with Type 2 diabetes use an insulin pump?

People with insulin-treated Type 2 diabetes may use an insulin pump to simplify insulin delivery, reduce daily management burden, and improve glucose control. Treatment decisions should always be made with a healthcare provider.

Is Omnipod approved for Type 2 diabetes worldwide?

Availability, regulatory approvals, and reimbursement policies vary by country. Always consult local healthcare providers and official Omnipod resources for the most up-to-date information.

Sources

• Insulet Investor Relations – Omnipod 5 FDA Clearance for Type 2 Diabetes
• Omnipod 5 for Type 2 Diabetes Information
• SECURE-T2D Clinical Outcomes
• JAMA Network Open – Automated Insulin Delivery in Adults With Type 2 Diabetes

Medical Disclaimer

This article is for educational and informational purposes only and should not be considered medical advice. Diabetes treatment decisions should always be made in consultation with a qualified healthcare professional. Availability, indications, reimbursement, and regulatory approvals for Omnipod products may vary by country and may change over time. Always consult official product documentation and your healthcare team before making changes to your diabetes management plan.